EUCTR2011-005343-27-NL进行中（未招募）1 期
Can metformin prevent endothelial ischemia and reperfusion injury? The Metformin-FMD trial. - The Metformin-FMD trial.
Radboud University Nijmegen Medical Centre0 个研究点目标入组 25 人开始时间: 2012年1月16日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-Age 30-50 years
- •-Written informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Hypertension (in supine position: systole > 140 mmgHg, diastole > 90 mmHg)
- •-Hyperlipidaemia (fasting total cholesterol > 5.5 mmol/L or random > 6.5 mmol/L)
- •-Diabetes Mellitus (fasting glucose > 7.0 mmol/L or random glucose > 11.0 mmol/L)
- •-History of any cardiovascular disease
- •-Concomitant chronic use of medication
- •-Renal dysfunction (MDRD < 60 ml/min)
- •-Professional athletes
研究者
相似试验
招募中
4 期
Can metformin prevent endothelial ischemia and reperfusion injury? The metformin-FMD trial.ischemia and reperfusion injury10003216NL-OMON37620niversitair Medisch Centrum Sint Radboud26
已完成
4 期
The Metformin-FMD TrialIschemia Reperfusion InjuryEndothelial FunctionNCT01610401Radboud University Medical Center26
已完成
不适用
Metformin improves endothelial function, endothelial progenitor cells and cardiovascular risk factors in type 1 diabetesType 1 diabetes and cardiovascular diseaseNutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusISRCTN26092132Gateshead Health NHS Foundation Trust (UK)46
招募中
4 期
Investigating the effect of metformin on vascular function and cardiovascular risk factors in children and adolescents with type 1 diabetesType 1 diabetes mellitusIRCT20230930059564N1Shahid Beheshti University of Medical Sciences52
已完成
不适用
The effects of metformin on vascular function and adipocyte AMP-activated protein kinase (AMPK) activation in type 2 diabetesISRCTN51336867Greater Glasgow Health Board (North Glasgow University Hospitals Division) (UK)20